UBS Cuts Hercules Capital (HTGC) Target as BDC Outlook Remains Mixed

Core Insights - Hercules Capital, Inc. (NYSE:HTGC) is recognized as one of the 13 Extreme Dividend Stocks with significant upside potential [1] - UBS has reduced its price target for Hercules Capital from $19.50 to $15 while maintaining a Neutral rating on the shares [2] Financial Performance - In the Q4 2025 earnings call, CEO Scott Bluestein reported record operating performance for the year, with originations reaching nearly $4 billion and gross fundings totaling approximately $2.28 billion [3] - The company achieved new annual records for total and net investment income, covering 120% of its quarterly base distribution of $0.40 per share in Q4 [3] - Hercules Capital maintained a spillover income of $0.82 per share and plans to continue its supplemental distribution from the previous year [4] - Assets under management increased to over $5.7 billion, reflecting a growth of over 20% compared to year-end 2024 [4] - The company reported record new debt and equity commitments of $3.92 billion, a 45.7% increase year over year, along with net debt portfolio growth of approximately $748.5 million [4] Company Overview - Hercules Capital, Inc. is a specialty finance company that provides financing solutions to venture capital-backed and institutional-backed companies in technology and life sciences sectors [5]